Has Jim Cheung, MD received payments from drug or device companies?

Yes. Drug and device makers reported $116,028 in general payments to Jim Cheung, MD across 218 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jim Cheung, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jim Cheung, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jim Cheung, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1366489700

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 35.6% of the total. Reporting peaked in 2023 at $31,155 and has fallen 80.9% since, to $5,957 in 2025.

$116,028in general payments, 2019–2025

Across 218 payments — averaging $532.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$41K
Abbott$35K
Biotronik Inc.$17K
Boston Scientific$13K
Biosense Webster, Inc.$7K
Stereotaxis Inc$1K
plus $1K from 4 others

$665,124in research payments, 2019–2025

Across 84 payments — averaging $7918.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$389K
Medtronic$150K
Adagio Medical, Inc.$122K
Novartis$3K
Biotronik Inc.$1K

What the payments were for

Consulting fees$30,75527%
Speaking & faculty fees$64,67556%
Grants$7501%
Travel & lodging$12,61311%
Food & beverage$6,8776%
Education$3580%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	68	$41,332
Abbott	65	$35,197
Biotronik Inc.	44	$16,981
Boston Scientific	23	$13,173
Biosense Webster, Inc.	10	$6,721
Stereotaxis Inc	1	$1,140
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$1,000
Atricure, Inc.	4	$429
E.r. Squibb & Sons, L.L.C.	1	$32
Cardiva Medical, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Ensite Cardiac Mapping System$14,925
GENERAL - THERAPIES$7,622
EnSite Precision Cardiac Mapping System$6,875
Carto 3$6,479
ENSITE PRECISION$6,325
BioMonitor$2,684
VersaCross Steerable Access Solution$2,500
Solia$2,398
VersaCross Access Solution$2,375
EVERA MRI XT DR SURESCAN$2,358
Mitra Clip system$2,200
Rivacor$1,550
Edora$1,550
Acticor$1,550
TENDRIL$1,453
Acticor 7 VR-T DX$1,206
Niobe$1,140
LifeVest$1,000
CROME DR MRI SURESCAN$896
Rivacor 7 DR-T$848

How this compares

$116,028 in reported general payments places this provider in the 85th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$390,504

Medicare patients

779

Services billed

3,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	168	$202,279
MultaqDronedarone Hcl	29	$37,940
XareltoRivaroxaban	23	$29,596
Dofetilide	43	$6,139
Propafenone Hcl ErPropafenone Hcl	14	$2,535
Amiodarone Hcl	46	$1,974
Metoprolol Succinate	93	$1,518

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Christopher LiuNew York$181K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →